Tapewire

NYSE · USD

JNJ

JOHNSON & JOHNSON

Export transactions ↓
Tapewire entity
2722
SEC CIK
0000200406
Parsed reports
1,771

Last 12 months

Inside the activity.

1 purchase rows · 28 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202602
Feb 2026015
Mar 202600
Apr 202600
May 202600
Jun 202601
Jul 202601
Aug 202607
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 15, 2022 Filed Feb 17, 2022 11:01 UTC
Decker Robert JController, CAO
Tax withholdingCommon Stock 248 $165.89 $41,140.72
Disclosure

SEC source: 0001225208-22-002378 · doc4.xml · nonDerivative · entry 2

Decker Robert J · CIK 0001798703 · Controller, CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,473

F2 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:01 UTC
Decker Robert JController, CAO
Exercise / conversionCommon Stock 903 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002378 · doc4.xml · nonDerivative · entry 1

Decker Robert J · CIK 0001798703 · Controller, CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,721

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 21:46 UTC GrantDeferred Share Units · Derivative 1,175 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002576 · doc4.xml · derivative · entry 1

Beckerle Mary C · CIK 0001520181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,355.318

Underlying: Common Stock · 1,175 shares

Expires not disclosed

F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
February 15, 2022 Filed Feb 17, 2022 21:46 UTC GrantDeferred Share Units · Derivative 1,175 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002577 · doc4.xml · derivative · entry 1

DAVIS D SCOTT · CIK 0001227733 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,196.532

Underlying: Common Stock · 1,175 shares

Expires not disclosed

F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
February 15, 2022 Filed Feb 17, 2022 21:46 UTC
Davis IanDirector
GrantDeferred Share Units · Derivative 1,175 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002578 · doc4.xml · derivative · entry 1

Davis Ian · CIK 0001494009 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,706.039

Underlying: Common Stock · 1,175 shares

Expires not disclosed

F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
February 15, 2022 Filed Feb 17, 2022 21:46 UTC GrantDeferred Share Units · Derivative 1,175 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002579 · doc4.xml · derivative · entry 1

Doudna Jennifer A · CIK 0001739090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,132.765

Underlying: Common Stock · 1,175 shares

Expires not disclosed

F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
February 15, 2022 Filed Feb 17, 2022 21:46 UTC GrantDeferred Share Units · Derivative 1,175 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002581 · doc4.xml · derivative · entry 1

McClellan Mark B. · CIK 0001567006 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,322.637

Underlying: Common Stock · 1,175 shares

Expires not disclosed

F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
February 15, 2022 Filed Feb 17, 2022 21:46 UTC
Joly HubertDirector
GrantDeferred Share Units · Derivative 1,175 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002580 · doc4.xml · derivative · entry 1

Joly Hubert · CIK 0001467638 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,613.814

Underlying: Common Stock · 1,175 shares

Expires not disclosed

F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
February 15, 2022 Filed Feb 17, 2022 21:47 UTC GrantDeferred Share Units · Derivative 1,175 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002582 · doc4.xml · derivative · entry 1

MULCAHY ANNE M · CIK 0001201725 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,706.039

Underlying: Common Stock · 1,175 shares

Expires not disclosed

F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
February 15, 2022 Filed Feb 17, 2022 21:47 UTC GrantDeferred Share Units · Derivative 1,175 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002584 · doc4.xml · derivative · entry 1

WILLIAMS RONALD A · CIK 0001185243 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,673

Underlying: Common Stock · 1,175 shares

Expires not disclosed

F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
February 15, 2022 Filed Feb 17, 2022 21:47 UTC
West NadjaDirector
GrantDeferred Share Units · Derivative 1,175 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002583 · doc4.xml · derivative · entry 1

West Nadja · CIK 0001787802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,326.845

Underlying: Common Stock · 1,175 shares

Expires not disclosed

F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
February 15, 2022 Filed Feb 17, 2022 21:47 UTC GrantDeferred Share Units · Derivative 1,175 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002586 · doc4.xml · derivative · entry 1

Washington A. Eugene · CIK 0001561989 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,733.9293

Underlying: Common Stock · 1,175 shares

Expires not disclosed

F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
February 15, 2022 Filed Feb 17, 2022 21:47 UTC GrantDeferred Share Units · Derivative 1,175 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002585 · doc4.xml · derivative · entry 1

HEWSON MARILLYN A · CIK 0001217496 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,205.367

Underlying: Common Stock · 1,175 shares

Expires not disclosed

F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
February 15, 2022 Filed Feb 17, 2022 21:47 UTC GrantDeferred Share Units · Derivative 1,175 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002587 · doc4.xml · derivative · entry 1

WEINBERGER MARK A · CIK 0001785997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,288.753

Underlying: Common Stock · 1,175 shares

Expires not disclosed

F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
February 15, 2022 Filed Feb 17, 2022 21:47 UTC GrantDeferred Share Units · Derivative 1,175 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002588 · doc4.xml · derivative · entry 1

PRINCE CHARLES · CIK 0001225179 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,823.78

Underlying: Common Stock · 1,175 shares

Expires not disclosed

F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
February 15, 2022 Filed Feb 19, 2022 00:15 UTC
Hait WilliamSee Remarks
Exercise / conversionPerformance Share Units · Derivative 8,128 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002823 · doc4.xml · derivative · entry 5

Hait William · CIK 0001904791 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 775

Underlying: Common Stock · 8,128 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.

F5 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.

Read SEC document
February 15, 2022 Filed Feb 19, 2022 00:15 UTC
Hait WilliamSee Remarks
Tax withholdingCommon Stock 4,158 $165.89 $689,770.62
Disclosure

SEC source: 0001225208-22-002823 · doc4.xml · nonDerivative · entry 2

Hait William · CIK 0001904791 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,236

F2 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units.

Read SEC document
February 15, 2022 Filed Feb 19, 2022 00:15 UTC
Hait WilliamSee Remarks
Exercise / conversionCommon Stock 8,128 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002823 · doc4.xml · nonDerivative · entry 1

Hait William · CIK 0001904791 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,394

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 15, 2022 Filed Feb 25, 2022 21:36 UTC GrantDeferred Share Units · Derivative 1,030 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-003428 · doc4.xml · derivative · entry 1

Adamczyk Darius · CIK 0001605056 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,030

Underlying: Common Stock · 1,030 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:02 UTC
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
Exercise / conversionRestricted Share Units · Derivative 3,297 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002211 · doc4.xml · derivative · entry 3

Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,297 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:02 UTC
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
Tax withholdingCommon Stock 1,190 $168.85 $200,931.50
Disclosure

SEC source: 0001225208-22-002211 · doc4.xml · nonDerivative · entry 2

Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,233.001

F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:02 UTC
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
Exercise / conversionCommon Stock 3,297 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002211 · doc4.xml · nonDerivative · entry 1

Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,423.001

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:02 UTC
Fasolo PeterExec VP, Chief HR Officer
Exercise / conversionRestricted Share Units · Derivative 2,036 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002212 · doc4.xml · derivative · entry 3

Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,036 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:02 UTC
Fasolo PeterExec VP, Chief HR Officer
Tax withholdingCommon Stock 743 $168.85 $125,455.55
Disclosure

SEC source: 0001225208-22-002212 · doc4.xml · nonDerivative · entry 2

Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,636.0055

F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:02 UTC
Fasolo PeterExec VP, Chief HR Officer
Exercise / conversionCommon Stock 2,036 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002212 · doc4.xml · nonDerivative · entry 1

Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,379.0055

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:02 UTC
Decker Robert JController, CAO
Exercise / conversionRestricted Share Units · Derivative 866 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002213 · doc4.xml · derivative · entry 5

Decker Robert J · CIK 0001798703 · Controller, CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 866 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:02 UTC
Decker Robert JController, CAO
Tax withholdingCommon Stock 263 $168.85 $44,407.55
Disclosure

SEC source: 0001225208-22-002213 · doc4.xml · nonDerivative · entry 2

Decker Robert J · CIK 0001798703 · Controller, CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,818

F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:02 UTC
Decker Robert JController, CAO
Exercise / conversionCommon Stock 866 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002213 · doc4.xml · nonDerivative · entry 1

Decker Robert J · CIK 0001798703 · Controller, CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,081

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:03 UTC
McEvoy AshleyEVP, WW Chair, Medical Devices
Exercise / conversionRestricted Share Units · Derivative 2,885 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002214 · doc4.xml · derivative · entry 5

McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,885 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:03 UTC
McEvoy AshleyEVP, WW Chair, Medical Devices
Tax withholdingCommon Stock 792 $168.85 $133,729.20
Disclosure

SEC source: 0001225208-22-002214 · doc4.xml · nonDerivative · entry 2

McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,248.9545

F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:03 UTC
McEvoy AshleyEVP, WW Chair, Medical Devices
Exercise / conversionCommon Stock 2,885 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002214 · doc4.xml · nonDerivative · entry 1

McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,040.9545

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:03 UTC
Ullmann Michael HExec VP, General Counsel
Exercise / conversionRestricted Share Units · Derivative 2,407 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002216 · doc4.xml · derivative · entry 7

Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,407 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

F2 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:03 UTC
Ullmann Michael HExec VP, General Counsel
Tax withholdingCommon Stock 871 $168.85 $147,068.35
Disclosure

SEC source: 0001225208-22-002216 · doc4.xml · nonDerivative · entry 4

Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,857.882

F3 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:03 UTC
Ullmann Michael HExec VP, General Counsel
Exercise / conversionCommon Stock 2,407 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002216 · doc4.xml · nonDerivative · entry 3

Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,728.882

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:03 UTC
Mongon ThibautExec VP, WW Chair, Consumer
Exercise / conversionRestricted Share Units · Derivative 3,759 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002215 · doc4.xml · derivative · entry 3

Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,759 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:03 UTC
Mongon ThibautExec VP, WW Chair, Consumer
Tax withholdingCommon Stock 1,520 $168.85 $256,652.00
Disclosure

SEC source: 0001225208-22-002215 · doc4.xml · nonDerivative · entry 2

Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,824.2661

F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:03 UTC
Mongon ThibautExec VP, WW Chair, Consumer
Exercise / conversionCommon Stock 3,759 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002215 · doc4.xml · nonDerivative · entry 1

Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,344.2661

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:03 UTC
Wengel Kathryn EEVP, Chief GSC Officer
Exercise / conversionRestricted Share Units · Derivative 1,896 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002217 · doc4.xml · derivative · entry 5

Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,896 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:03 UTC
Wengel Kathryn EEVP, Chief GSC Officer
Tax withholdingCommon Stock 695 $168.85 $117,350.75
Disclosure

SEC source: 0001225208-22-002217 · doc4.xml · nonDerivative · entry 2

Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,623.8735

F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:03 UTC
Wengel Kathryn EEVP, Chief GSC Officer
Exercise / conversionCommon Stock 1,896 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002217 · doc4.xml · nonDerivative · entry 1

Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,318.8735

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:04 UTC
Wolk Joseph JExec VP, CFO
Exercise / conversionRestricted Share Units · Derivative 3,248 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002218 · doc4.xml · derivative · entry 4

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,248 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:04 UTC
Wolk Joseph JExec VP, CFO
Tax withholdingCommon Stock 921 $168.85 $155,510.85
Disclosure

SEC source: 0001225208-22-002218 · doc4.xml · nonDerivative · entry 2

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,384.204

F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:04 UTC
Wolk Joseph JExec VP, CFO
Exercise / conversionCommon Stock 3,248 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002218 · doc4.xml · nonDerivative · entry 1

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,305.204

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:03 UTC
Broadhurst VanessaEVP, Global Corp Aff.
Exercise / conversionRestricted Share Units · Derivative 2,451 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002219 · doc4.xml · derivative · entry 3

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Aff.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,451 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:03 UTC
Broadhurst VanessaEVP, Global Corp Aff.
Tax withholdingCommon Stock 902 $168.85 $152,302.70
Disclosure

SEC source: 0001225208-22-002219 · doc4.xml · nonDerivative · entry 2

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Aff.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,035

F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:03 UTC
Broadhurst VanessaEVP, Global Corp Aff.
Exercise / conversionCommon Stock 2,451 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002219 · doc4.xml · nonDerivative · entry 1

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Aff.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,937

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:03 UTC
Mammen MathaiEVP, Pharm, R&D
Exercise / conversionRestricted Share Units · Derivative 7,418 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002220 · doc4.xml · derivative · entry 3

Mammen Mathai · CIK 0001421050 · EVP, Pharm, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,418 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:03 UTC
Mammen MathaiEVP, Pharm, R&D
Tax withholdingCommon Stock 2,335 $168.85 $394,264.75
Disclosure

SEC source: 0001225208-22-002220 · doc4.xml · nonDerivative · entry 2

Mammen Mathai · CIK 0001421050 · EVP, Pharm, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,560

F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:03 UTC
Mammen MathaiEVP, Pharm, R&D
Exercise / conversionCommon Stock 7,418 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002220 · doc4.xml · nonDerivative · entry 1

Mammen Mathai · CIK 0001421050 · EVP, Pharm, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,895

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 01:04 UTC
Hait WilliamSee Remarks
Exercise / conversionRestricted Share Units · Derivative 7,790 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002221 · doc4.xml · derivative · entry 3

Hait William · CIK 0001904791 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,790 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.